Effectiveness of bladder filling control during online MR-guided adaptive radiotherapy for rectal cancer

被引:2
|
作者
Feng, Xi [1 ,2 ]
Tang, Bin [1 ,2 ]
Yao, Xinghong [1 ,2 ]
Liu, Min [1 ,2 ,3 ]
Liao, Xiongfei [1 ,2 ]
Yuan, Ke [1 ,2 ]
Peng, Qian [1 ,2 ]
Orlandini, Lucia Clara [1 ,2 ]
机构
[1] Univ Elect Sci & Technol China, Affiliated Canc Hosp, Sichuan Canc Hosp & Inst, Dept Radiat Oncol, Chengdu, Peoples R China
[2] Sichuan Clin Res Ctr Canc, Sichuan Canc Ctr, Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China
[3] Chengdu Univ Technol, Inst Nucl Technol & Automation Engn, Chengdu, Peoples R China
关键词
Radiotherapy; MR-Linac; Rectum; Adaptive radiotherapy; Magnetic resonance imaging; Bladder control; RADIATION-THERAPY; ELECTRON-DENSITY; CT IMAGES; PROSTATE; GENERATION; TOXICITY; VOLUME; LINAC;
D O I
10.1186/s13014-023-02315-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Magnetic resonance-guided adaptive radiotherapy (MRgART) treatment sessions at MR-Linac are time-consuming and changes in organs at risk volumes can impact the treatment dosimetry. This study aims to evaluate the feasibility to control bladder filling during the rectum MRgART online session and its effectiveness on plan dosimetry. Methods A total of 109 online adaptive sessions of 24 rectum cancer patients treated at Unity 1.5 T MR-Linac with a short course radiotherapy (25 Gy, 5 Gy x 5) for whom the adaptive plan was optimized and recalculated online based on the daily magnetic resonance imaging (MRI) were analysed. Patients were fitted with a bladder catheter to control bladder filling; the bladder is emptied and then partially filled with a known amount of saline at the beginning and end of the online session. A first MRI (MRIi) acquired at the beginning of the session was used for plan adaptation and the second (MRIf) was acquired while approving the adapted plan and rigidly registered with the first to ensure the appropriateness of the isodoses on the ongoing delivery treatment. For each fraction, the time interval between the two MRIs and potential bladder changes were assessed with independent metrics, and the impact on the plan dosimetry was evaluated by comparing target and organs at risk dose volume histogram cut-off points of the plan adapted on MRIi and recalculated on MRIf. Results Median bladder volume variations, DSC, and HD of 8.17%, 0.922, and 2.92 mm were registered within a median time of 38 min between MRIi and MRIf; dosimetric differences < 0.65% were registered for target coverage, and < 0.5% for bladder, small bowel and femoral heads constraints, with a p value > 0.05. Conclusion The use of a bladder filling control procedure can help ensure the dosimetric accuracy of the online adapted treatment delivered.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer
    de Ridder, Mischa
    Raaijmakers, Cornelis P. J.
    Pameijer, Frank A.
    de Bree, Remco
    Reinders, Floris C. J.
    Doornaert, Patricia A. H.
    Terhaard, Chris H. J.
    Philippens, Marielle E. P.
    CANCERS, 2022, 14 (12)
  • [32] Automated Treatment Planning for adaptive MR-guided Radiotherapy of Prostate Cancer
    Tengler, B.
    Hagmueller, M.
    Kuenzel, L. A.
    Nachbar, M.
    Moennich, D.
    Boeke, S.
    Gani, C.
    Zips, D.
    Thorwarth, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2022, 198 (SUPPL 1) : S17 - S17
  • [33] Feasibility of neurovascular sparing MR-guided adaptive radiotherapy for prostate cancer
    Teunissen, F.
    Wortel, R.
    Hes, J.
    Willigenburg, T.
    de Boer, J.
    Meijer, R.
    van Melick, H.
    Verkooijen, H.
    van Zyp, J. van der Voort
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1126 - S1127
  • [34] Feasibility of Stereotactic MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer
    Mustafayev, T. Z.
    Atalar, B.
    Gungor, G.
    Sengoz, M.
    Abacioglu, U.
    Ozyar, E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E916 - E916
  • [35] Qntifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy
    Farjam, Reza
    Mahase, Sean S.
    Chen, Shu Ling
    Coonce, Madeline
    Pennell, Ryan T.
    Fecteau, Ryan
    Chughtai, Bilal
    Dewyngaert, J. Keith
    Kang, Josephine
    Ch Formenti, Silvia
    Nagar, Himanshu
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2021, 22 (09): : 49 - 58
  • [36] MOREOVER: multiomics MR-guided radiotherapy optimization in locally advanced rectal cancer
    Boldrini, Luca
    Chiloiro, Giuditta
    Di Franco, Silvia
    Romano, Angela
    Smiljanic, Lana
    Tran, Elena Huong
    Bono, Francesco
    Davies, Diepriye Charles
    Lopetuso, Loris
    De Bonis, Maria
    Minucci, Angelo
    Giaco, Luciano
    Cusumano, Davide
    Placidi, Lorenzo
    Giannarelli, Diana
    Sala, Evis
    Gambacorta, Maria Antonietta
    RADIATION ONCOLOGY, 2024, 19 (01)
  • [37] MR-guided radiotherapy in rectal cancer: First clinical experience of an innovative technology
    Chiloiro, Giuditta
    Boldrini, Luca
    Meldolesi, Elisa
    Re, Alessia
    Cellini, Francesco
    Cusumano, Davide
    Corvari, Barbara
    Mantini, Giovanna
    Balducci, Mario
    Valentini, Vincenzo
    Gambacorta, Maria Antonietta
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2019, 18 : 80 - 86
  • [38] Analysis of rectal dose during prostate stereotactic body radiotherapy in MR-guided radiotherapy.
    Sritharan, Kobika
    Dunlop, Alex
    Mitchell, Adam
    Mohajer, Jonathan
    Smith, Gillian
    Tree, Alison
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [39] Bladder filling variation during conformal radiotherapy for rectal cancer
    Sithamparam, S.
    Ahmad, R.
    Sabarudin, A.
    Othman, Z.
    Ismail, M.
    10TH INTERNATIONAL SEMINAR ON MEDICAL PHYSICS & 1ST AMDI INTERNATIONAL ONCOLOGY SYMPOSIUM, 2017, 851
  • [40] Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
    Schaule, J.
    Chamberlain, M.
    Wilke, L.
    Baumgartl, M.
    Krayenbuhl, J.
    Zamburlini, M.
    Mayinger, M.
    Andratschke, N.
    Tanadini-Lang, S.
    Guckenberger, M.
    RADIATION ONCOLOGY, 2021, 16 (01)